The historical rank and industry rank for Syneron Medical's Gross Margin % or its related term are showing as below:
ELOS's Gross Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 53.335 * Ranked among companies with meaningful Gross Margin % only.
Syneron Medical had a gross margin of 51.16% for the quarter that ended in Mar. 2017 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Syneron Medical was 0.00% per year.
Syneron Medical Gross Margin % Historical Data
The historical data trend for Syneron Medical's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Syneron Medical's Gross Margin %
For the Medical Devices subindustry, Syneron Medical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Syneron Medical's Gross Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Syneron Medical's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Syneron Medical's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Syneron Medical (NAS:ELOS) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Syneron Medical had a gross margin of 51.16% for the quarter that ended in Mar. 2017 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Syneron Medical Gross Margin % Related Terms
Thank you for viewing the detailed overview of Syneron Medical's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Syneron Medical (Syneron Medical) Business Description
Syneron Medical Ltd., was incorporated in the State of Israel in July 2000. The Company completed its initial public offering of ordinary shares in August 2004. It designs, develops and markets aesthetic medical products based on its various technologies including its proprietary Electro-Optical Synergy, or ELOS, technology, which uses the synergy between electrical energy, including radiofrequency or RF energy, and optical energy to provide effective, safe and affordable aesthetic medical treatments. The Company's products, which it sells mainly to physicians and other practitioners, target non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin and laser-assisted lipolysis and topical skin brightening products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ELOS has been successfully added to your 